Zhenzhen Wu

910 total citations
46 papers, 649 citations indexed

About

Zhenzhen Wu is a scholar working on Physiology, Molecular Biology and Nephrology. According to data from OpenAlex, Zhenzhen Wu has authored 46 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Molecular Biology and 6 papers in Nephrology. Recurrent topics in Zhenzhen Wu's work include Salivary Gland Disorders and Functions (10 papers), Renal Diseases and Glomerulopathies (6 papers) and COVID-19 and Mental Health (4 papers). Zhenzhen Wu is often cited by papers focused on Salivary Gland Disorders and Functions (10 papers), Renal Diseases and Glomerulopathies (6 papers) and COVID-19 and Mental Health (4 papers). Zhenzhen Wu collaborates with scholars based in China, United States and United Kingdom. Zhenzhen Wu's co-authors include Pingfu Feng, Kingman P. Strohl, Drina Vurbic, Yuan Hu, Leslie A. Bruggeman, KP Strohl, Zhaohui Zheng, Congcong Gao, Yong Wang and Wei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zhenzhen Wu

45 papers receiving 643 citations

Peers

Zhenzhen Wu

NEPHR

PHYSI

EAS

Michelle Stewart United Kingdom

Irene Pichler Italy

Justin Davis United States

Laura Southgate United Kingdom

Tingting Xu China

S E Walker United States

Barry B. Bercu United States

Raj K. Maturi United States

Marina Mancini Italy

Michelle Stewart United Kingdom

Zhenzhen Wu

204 ×1.4

39 ×0.4

53 ×0.6

NEPHR

63 ×0.7

PHYSI

22 ×0.3

EAS

Citations per year, relative to Zhenzhen Wu Zhenzhen Wu (= 1×) peers Michelle Stewart

Countries citing papers authored by Zhenzhen Wu

Since Specialization

Citations

This map shows the geographic impact of Zhenzhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhen Wu more than expected).

Fields of papers citing papers by Zhenzhen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhen Wu. The network helps show where Zhenzhen Wu may publish in the future.

Co-authorship network of co-authors of Zhenzhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhen Wu. A scholar is included among the top collaborators of Zhenzhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhen Wu. Zhenzhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Qiuming, Zhi Ting Ye, Junxi Wang, et al.. (2025). Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities. SHILAP Revista de lepidopterología. 3(3). 1 indexed citations

Wu, Zhenzhen, et al.. (2025). Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases. Autoimmunity Reviews. 24(6). 103823–103823. 5 indexed citations

Wang, Jian, Xinran Jiang, Yaqin Zhao, et al.. (2025). Galvanic Cell‐Stimulated Mesenchymal Stem Cell Mesh for Enhanced Pelvic Organ Prolapse Treatment. Advanced Healthcare Materials. 14(12). e2403603–e2403603. 2 indexed citations

Han, Fang, Yuanyuan Liang, Zhenzhen Wu, et al.. (2025). Dynamics of serum tumor markers may indicate the progression of interstitial lung disease in Sjögren’s syndrome patients: new roles for old friends. Clinical and Experimental Medicine. 25(1). 229–229.

Liang, Yuanyuan, Li Cai, Fang Han, et al.. (2024). Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China. Immunology Letters. 267. 106865–106865. 6 indexed citations

Liang, Yuanyuan, et al.. (2023). Predicting cardiovascular risk in a Chinese primary Sjögren’s syndrome population: development and assessment of a predictive nomogram. Therapeutic Advances in Chronic Disease. 14. 384230066–384230066. 3 indexed citations

Nguyen, Jane, et al.. (2023). Local Inflammation But Not Kidney Cell Infection Associated with High APOL1 Expression in COVID-Associated Nephropathy. Kidney360. 4(12). 1757–1762. 4 indexed citations

Wu, Zhenzhen, et al.. (2023). Tofacitinib in the treatment of primary Sjögren’s syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial. BMC Pulmonary Medicine. 23(1). 473–473. 5 indexed citations

Wu, Zhenzhen, et al.. (2023). Osteoarthritis or arthritis? Toward understanding of primary Sjögren’s syndrome patients with arthralgia. Journal of Orthopaedic Surgery and Research. 18(1). 41–41. 4 indexed citations

10.

Liang, Yuanyuan, et al.. (2022). Potential Mechanisms of White Peony against Primary Sjögren’s Syndrome Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 3 indexed citations

11.

Wu, Qiuxia, Tao Luo, Jinsong Tang, et al.. (2022). Gaming in China Before the COVID-19 Pandemic and After the Lifting of Lockdowns: a Nationwide Online Retrospective Survey. International Journal of Mental Health and Addiction. 21(5). 3293–3305. 18 indexed citations

12.

Wu, Zhenzhen, Sethu M. Madhavan, Michelle Chen, et al.. (2021). Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys. PLoS ONE. 16(6). e0253197–e0253197. 4 indexed citations

13.

Fan, Yi, Yajun Liu, Zhenzhen Wu, et al.. (2021). Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. Cancer Cell International. 21(1). 526–526. 14 indexed citations

14.

Huang, Kai, Xinxin Chen, Yuzhu Hao, et al.. (2021). A Quasi-Experimental Study on the Effectiveness of Compulsory and Voluntary Treatment Settings for 1,299 Drug Abusers in Hunan, China. Frontiers in Psychiatry. 12. 613665–613665. 5 indexed citations

15.

Wang, Shujuan, Yu Zhang, Yajun Liu, et al.. (2020). <p>Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia</p>. OncoTargets and Therapy. Volume 13. 12549–12560. 7 indexed citations

16.

Liao, Yanhui, Ling Wang, Tao Luo, et al.. (2020). Brief mindfulness-based intervention of ‘STOP (Stop, Take a Breath, Observe, Proceed) touching your face’: a study protocol of a randomised controlled trial. BMJ Open. 10(11). e041364–e041364. 9 indexed citations

17.

Wang, Shujuan, Zhenzhen Wu, Yafei Li, et al.. (2020). Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia. Scientific Reports. 10(1). 12152–12152. 23 indexed citations

18.

Wang, Yunfei, Maorong Hu, Shiyou Wu, et al.. (2020). Alcohol Consumption in China Before and During COVID-19: Preliminary Results From an Online Retrospective Survey. Frontiers in Psychiatry. 11. 597826–597826. 39 indexed citations

19.

Prakash, Sindhuri, Natalia Papeta, Roel Sterken, et al.. (2011). Identification of the Nephropathy-Susceptibility Locus HIVAN4. Journal of the American Society of Nephrology. 22(8). 1497–1504. 9 indexed citations

20.

Wu, Zhenzhen, Jenny Ziembicki, Junko Nagano, et al.. (2005). Role of ceramide in Ca2+-sensing receptor-induced apoptosis. Journal of Lipid Research. 46(7). 1396–1404. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact